Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Insulin aspart by Gan & Lee Pharmaceuticals for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin aspart is under clinical development by Gan & Lee Pharmaceuticals and currently in Pre-Registration for Type 1 Diabetes (Juvenile...
Insulin aspart by Gan & Lee Pharmaceuticals for Type 2 Diabetes: Likelihood of Approval
Insulin aspart is under clinical development by Gan & Lee Pharmaceuticals and currently in Pre-Registration for Type 2 Diabetes. According...
Insulin aspart by Amphastar Pharmaceuticals for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin aspart is under clinical development by Amphastar Pharmaceuticals and currently in Pre-Registration for Type 1 Diabetes (Juvenile Diabetes). According...
Insulin aspart by Amphastar Pharmaceuticals for Type 2 Diabetes: Likelihood of Approval
Insulin aspart is under clinical development by Amphastar Pharmaceuticals and currently in Pre-Registration for Type 2 Diabetes. According to GlobalData,...